Anti-miRNA oligonucleotides: A comprehensive guide for design
Explore this paper's citation graph
Summary
From the design strategies used in AMOs to its application in novel miRNA-based therapeutics and detection methodologies, this review outlines the technologies involved to suppress aberrant miRNAs.
- Type
- review
- Published
- 2018-03-04
- Cited by
- 237
- References
- 146
- Access
- Open access
- OpenAlex
- https://openalex.org/W2793471865
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:4173120
Keywords
microRNA, Biology, Gene silencing, Oligonucleotide, Locked nucleic acid
References
- Specificity, duplex degradation and subcellular localization of antagomirs
- Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes.
- Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide Modifier
- Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients.
- miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer
- The principles of MiRNA-masking antisense oligonucleotides technology.
- MicroRNA Interference Technologies
- The guideline of the design and validation of MiRNA mimics.
- Down‐regulation of microRNA‐9 leads to activation of IL‐6/Jak/STAT3 pathway through directly targeting IL‐6 in HeLa cell
- NAD(P)H and collagen as in vivo quantitative fluorescent biomarkers of epithelial precancerous changes.
- miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells
- Targeting Of miR9/NOTCH1 Interaction Reduces Metastatic Behavior in Triple‐negative Breast Cancer
- Mechanism of Translation Initiation in Eukaryotes
- Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
- Oncomirs — microRNAs with a role in cancer
- Towards a molecular understanding of microRNA-mediated gene silencing
- MicroRNA‐9 inhibits ovarian cancer cell growth through regulation of NF‐κB1
- MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma
- Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family
- Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats.
Cited by
- MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes
- Reply to Zhang and Zhu “MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19”
- MicroRNAs as a Potential Target for Cancer Therapy
- Selective Effects of mTOR Inhibitor Sirolimus on Naïve and CMV-Specific T Cells Extending Its Applicable Range Beyond Immunosuppression
- Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond
- Current Progress on MicroRNA-Based Gene Delivery in the Treatment of Osteoporosis and Osteoporotic Fracture
- Oligonucleotide–Palladacycle Conjugates as Splice-Correcting Agents
- Regulation of cancer-specific miRNAs by MDA-7/IL-24
- Addressing Alzheimer’s disease (AD) neuropathology using anti-microRNA (AM) strategies
- Current RNA-based Therapeutics in Clinical Trials.
- A combined experimental and computational study on peptide nucleic acid (PNA) analogues of tumor suppressive miRNA-34a.
- Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
- Novel MicroRNA Sponges to Specifically Modulate Gene Expression in Colon Cancer Cells
- Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments
- Peptide Nucleic Acids for MicroRNA Targeting.
- MicroRNA expression profile analysis in sperm reveals hsa-mir-191 as an auspicious omen of in vitro fertilization
- Clinical significance of miRNAs in autoimmunity.
- Chemical Synthesis and Biological Application of Modified Oligonucleotides.
- Investigating Ass1 and its role in renal fibrosis
- MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance
Related papers
- Synthesis of Oligonucleotides Containing 5'-Homo-4'-selenouridine Derivative and Its Increased Resistance against Nuclease.
- Enhanced recognition of non-complementary hybridization by single-LNA-modified oligonucleotide probes
- Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates
- Death without stress: The stiletto approach against disease
- Selective Protection of Nuclease-Sensitive Sites in siRNA Prolongs Silencing Effect
- Normalization of Overexpressed α-Synuclein Causing Parkinson's Disease By a Moderate Gene Silencing With RNA Interference.
- Quantitative MALDI-TOF MS of oligonucleotides and a nuclease assay
- [In vivo siRNA delivery to tumor cells and its application to cancer gene therapy].
- SID-I is implicated in systemic gene silencing in the honey bee
- Splice-switching efficiency and specificity for oligonucleotides with locked nucleic acid monomers.